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ABSTRACT: XCMS Online (xcmsonline.scripps.edu) is a cloud-based informatic
platform designed to process and visualize mass-spectrometry-based, untargeted
metabolomic data. Initially, the platform was developed for two-group comparisons to
match the independent, “control” versus “disease” experimental design. Here, we
introduce an enhanced XCMS Online interface that enables users to perform dependent
(paired) two-group comparisons, meta-analysis, and multigroup comparisons, with
comprehensive statistical output and interactive visualization tools. Newly incorporated
statistical tests cover a wide array of univariate analyses. Multigroup comparison allows
for the identification of differentially expressed metabolite features across multiple classes
of data while higher order meta-analysis facilitates the identification of shared metabolic
patterns across multiple two-group comparisons. Given the complexity of these data sets,
we have developed an interactive platform where users can monitor the statistical output
of univariate (cloud plots) and multivariate (PCA plots) data analysis in real time by
adjusting the threshold and range of various parameters. On the interactive cloud plot, metabolite features can be filtered out by
their significance level (p-value), fold change, mass-to-charge ratio, retention time, and intensity. The variation pattern of each
feature can be visualized on both extracted-ion chromatograms and box plots. The interactive principal component analysis
includes scores, loadings, and scree plots that can be adjusted depending on scaling criteria. The utility of XCMS functionalities is
demonstrated through the metabolomic analysis of bacterial stress response and the comparison of lymphoblastic leukemia cell
lines.
XCMS Online1 is a cloud-based, mass spectrometry dataprocessing platform that was developed in response to
the growing need for user-friendly software to process complex
untargeted metabolomic results.2−4 Currently, XCMS Online
has more than 4500 registered users from 120 different
countries. This web-based platform is an extension of the
original open-source R package XCMS that was released in
2006.5 Several open-source programs including MetAlign,6
MZmine,7 MAVEN,8 MetaboAnalyst,9 and XCMS,5 as well as
commercial programs, such as Mass Profiler Pro (Agilent) and
Metabolic Profiler (Bruker) have been successfully developed
to facilitate metabolomic data processing. Each of these
software tools has its own unique capabilities in supporting
metabolomic data storage, analysis, and annotation.10 How-
ever, these programs do not allow for complete metabolomic
data processing from feature detection and profile alignment to
feature annotation and exploratory statistical analyses. For
example, the web-based tools MetaboAnalyst and metaP-
Server,11 which have been mainly developed for targeted
metabolomic data analysis,12 perform comprehensive statistical
evaluation of preprocessed metabolomic data, yet rely on
external software to process the raw data.
XCMS Online has been designed as a solution for the entire
untargeted metabolomic workflow ranging from the computa-
tionally expensive raw data processing to direct metabolite
assignment through integration with the METLIN database.
The platform has been recently upgraded with data streaming
capabilities to support high-throughput, cloud-based data
processing.13 By continuous improvement of the platform,
we aim to facilitate the access and functional interpretation of
metabolomic data by scientists with limited background in
bioinformatics or statistics.
Our new interactive XCMS Online platform integrates
univariate and multivariate data processing, metabolite feature
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annotation, and metabolite identification. This easy-to-use
graphical interface has been significantly improved to support
the statistical analysis of more complex experimental designs. It
now performs two-group, multiple group, and meta-analysis
(Figure 1), providing XCMS Online users with a compre-
hensive univariate and multivariate statistical report through an
interactive display. Novel interactive visualization tools,
including two-group and multigroup cloud plots, principal
component analysis, and Venn and relational diagrams, have
been developed to deconvolve metabolomic data, simplify data
analysis, customize data output, and through integration with
METLIN, facilitate metabolite identification. The utility of
these approaches is demonstrated on several different data sets
that fit the experimental design of two-group comparison, of
meta-analysis, and of multigroup comparison (Figure 1).
■ EXPERIMENTAL SECTION
Bacterial Cultures. Wild-type and five different mutants of
Desulfovibrio alaskensis G20 were cultured in Wall lactate-
sulfate medium.14 The culture medium was supplemented with
0.1% yeast extract. The bacteria were grown at 30 °C in an
anaerobic growth chamber (Coy Laboratory Product, Inc.,
Grass Lake, MI). For exposing bacteria to salt stress, the
bacterial cells were washed in minimal media and grown in
minimal media to mid log phase (OD = 0.4) at 30 °C. At mid
log phase, sodium chloride was added to a final concentration
of 800 mM in the culture medium and the cells were cultured
for 1 h. The bacterial cells were collected by centrifugation
(4000g for 5 min) and the cell pellets were snap frozen in
liquid nitrogen and stored at −80 °C until the extraction.
Cell Culture. Cell culture and biological reagents Ramos
(CRL-1596), Raji (CCL-86), and SUP-T1 (CRL-1942) cell
lines were obtained from American Type Culture Collection
(ATCC, Manassas, VA, USA). Cell-culture conditions were as
described before.15
Human Blood Sampling. Human blood was sampled
from 20 normal, healthy subjects (10 males and 10 females)
recruited from the Normal Blood Donor Program and from
the general population of The Scripps Research Institute
employees. The samples were immediately transferred from
the heparin syringe into labeled aliquot tubes and centrifuged
at 4 °C at 2000 rpm for 20 min. Blood plasma was removed
and frozen at −80 °C.
Metabolite Extraction. The metabolites were extracted
from bacterial cell pellets (Desulfovibrio alaskensis G20) using a
MeOH/ACN/H2O (2:2:1, v/v) solvent mixture. One milliliter
of chilled solvent mixture was added to each bacterial pellet,
vortexed for 30 s, and flash frozen in liquid nitrogen for 1 min.
The samples were then allowed to thaw at room temperature
and sonicated in a water bath for 5 min. This cycle of cell lysis
in liquid nitrogen combined with sonication was repeated
three times. To precipitate proteins, the samples were
incubated for 1 h at −20 °C. The vials were centrifuged at
4 °C for 15 min at 13 000 rpm. The supernatant was collected
and evaporated to dryness in a vacuum concentrator. The dry
extracts were then reconstituted in 100 μL of ACN/H2O (1:1,
v/v), sonicated for 1 min and centrifuged at 4 °C for 15 min at
13 000 rpm. The supernatants were transferred to HPLC vials
and stored at −80 °C until LC/MS analysis.
Cell extractions and analyses were performed as described
before.16 For normalization, the cells were counted using the
Guava Viacount assay Millipore, Billerica, MA, USA) and
placed into 5 mL aliquots of 10 million cells per replicate
before extraction, to ensure uniform cell numbers in each
replicate.
Human plasma samples (200 μL) were extracted using 800
μL of cold MeOH/ACN (1:1, v/v). Protein precipitation and
dry extract reconstitution was performed as described above
for bacteria pellets.
LC/MS Analysis. Metabolite extracts from bacteria and
human blood plasma were analyzed on a 6538 Ultra High
Definition QTOF mass spectrometer (Agilent Technologies)
interfaced with a 1200 series HPLC system (Agilent
Technologies). Metabolite extracts from bacteria were analyzed
by HILIC/MS in ESI negative mode. A Phenomenex Luna
Aminopropyl column (3 μm, 150 mm × 1.0 mm I.D.) was
used for LC separation of metabolites for HILIC/MS analysis.
For HILIC, the mobile phase was composed of A = 10 mM
ammonium acetate and 10 mM ammonium hydroxide in 95%
water and B = 95% acetonitrile (pH-9.7). The samples were
loaded onto the column using 100% B (0−5 min) at a flow
rate of 50 μL/min and resolved using a linear gradient of 100%
B to 100% A over a period of 50 min (5−55 min). A 10 min
post-run was applied for HILIC, to ensure column re-
equilibration and maintain reproducibility.
Lymphoma metabolomic profiling was performed by RPLC/
MS in ESI positive mode. Samples were analyzed by using a
XBridge C18, 3.5 μm, 150 mm × 1.0 mm I.D. column
(Waters) and the standard mobile phase, A = 0.1% formic acid
in water and B = 0.1% formic acid in acetonitrile. A linear
gradient elution from 100% A (0−5 min) to 100% B (50−55
min) was applied.
Data Analysis. Data were analyzed by using interactive
XCMS Online, which is freely available at https://xcmsonline.
scripps.edu. The web interface has been developed for two-
group, meta-analysis, and multigroup analysis. It allows users
to either upload data sets using a java applet or select
preuploaded data sets on XCMS Online. Following the upload
Figure 1. Scheme representing the experimental design of two-group
comparison, meta-analysis, and multigroup analysis. Meta-analysis is a
higher-order analysis that aims to identify shared metabolic patterns
among multiple independent two-group comparisons. Shared
dysregulated features are represented by the region at the center of
the Venn diagram. In contrast, multigroup analysis aims to identify
differences between groups and reveal the diversity of metabolic
patterns across different groups: wt, bacterial wild type; mut, bacterial
mutant.
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of raw data files, users can select preset parameters (or
customize them) depending on the instrument platform in
which the data were acquired. The parameters are displayed in
the web browser using the jQuery-UI framework, with each tab
organized by category. Users can define parameters for
statistical analysis (parametric/nonparametric, paired/un-
paired) based on the type of experiment and data. The raw
data files are than processed for peak detection, retention-time
correction, chromatogram alignment, metabolite feature
annotation, statistical evaluation, and putative identification
through METLIN standard database matching. Metabolite
features are defined as ions with unique m/z and retention-
time values.
Parameter settings for XCMS processing of our demon-
stration data acquired by HILIC were as follows: centWave for
feature detection (Δ m/z = 15 ppm, minimum peak width =
10 s, and maximum peak width = 120 s); obiwarp settings for
retention-time correction (profStep = 1); and parameters for
chromatogram alignment, including mzwid = 0.015, minfrac =
0.5, and bw = 5. The relative quantification of metabolite
features was based on EIC (extracted ion chromatogram)
areas. For XCMS processing of reversed-phase LC data, we
used the same parameters except for chromatographic peak
width settings, which was set as minimum peak width = 10 s
and maximum peak width = 60 s. The results output, including
EICs, boxplots, cloud plots, Venn/Edwards diagrams and PCA,
were exported directly from XCMS Online.
■ RESULTS AND DISCUSSION
The XCMS Online platform was enhanced to implement
paired two-group comparisons, higher-order meta-analysis, and
multiple group comparisons. Additional statistical tests were
introduced, and the interactive visualization tools (Figures
2−7) were improved and developed to help deconvolve
complex untargeted metabolomic data sets. The statistical tests
are carried out systematically following feature detection and
profile alignment, providing users an interface to directly
visualize differentially expressed or significantly altered
metabolic features. Here we highlight the appropriate usage
of different statistical tests and demonstrate the value of
interactive, univariate (cloud plot), and multivariate (PCA
plots) visualization tools for different experimental designs:
two-group comparison, meta-analysis, and multigroup compar-
ison.
Two-Group Comparisons. The most common exper-
imental design in metabolomics is two-group analysis, where
“disease” and “control” or “before” and “af ter” treatment groups
are compared. Even in a simple two-group experiment,
choosing the right statistical test may be a challenging task
for users without a background in the field of biostatistics.
Depending on data distribution and experimental design,
XCMS Online offers the choice of parametric or non-
parametric, independent (unpaired) or dependent (paired)
two-group tests (Table 1). Parametric tests are applied when
the metabolomic data (peak area or intensity measurements)
meet the assumption of normal distribution. When these
conditions are not satisfied, the nonparametric alternative tests
should be used as they do not rely on assumptions about the
parameters of the data distribution.17 Parametric and non-
parametric tests can be used to assess the independent
(unpaired) and dependent (paired) sample groups. The
independent or unpaired group tests are designed to compare
means between two groups composed of different subjects
who were randomly selected (e.g., metabolic response in
“disease” versus “healthy” individuals). In the case of paired
tests, the subjects in both groups are the same (or matched
pairs) and therefore the mean difference between two repeated
observations (peak measurements) is compared (e.g., meta-
bolic response before and after drug treatment). When the
choice of paired test is made, the XCMS Online interface
provides a separate dialogue-box where users can align the
correct pairings by the “drag-n-drop” option.
In general, two-group tests allow users to determine the
metabolite features whose levels are significantly different
between two defined conditions. The examples from two
representative metabolomic experiments are shown in Figure
2. In the first example, Welch’s t test was used to evaluate the
metabolic response in bacteria subjected to nitric oxide stress
versus control grown in optimal conditions. Each compared
group had 5 independent biological replicates. Among the
many identified changes, the metabolic feature with m/z
171.005, putatively identified as glycerol-phosphate, was found
significantly down-regulated (p < 0.0001) in the stressed
bacterial population (Figure 2a). The second example
demonstrates the appropriate usage of a paired nonparametric
test or a Wilcoxon signed-rank test when comparing metabolic
profiles of arterial versus venous blood plasma from 20 human
individuals. Each compared group had 20 subjects from whom
Figure 2. Representative examples of independent and dependent
(paired) two-group experimental design. Extracted ion chromatogram
and box-plot/paired plot are shown for the features of interest. (A) A
significantly down-regulated (p < 0.001) metabolite feature (m/z
171.005; METLIN MS/MS match, glycerol phosphate) in independ-
ent group design (control versus stressed bacterial population) was
identified by using an independent parametric Welch t test. Welch’s t
test is used to compare the means of two independent sample groups
with the assumption that two-group variances may differ. (B) A
significantly higher level (p < 0.001) of metabolite feature (m/z
309.279; METLIN hit, eicosenoic acid) in arterial blood plasma was
determined by a paired nonparametric Wilcoxon test. Wilcoxon
signed-rank test is a nonparametric alternative to the paired t test
used to compare the related samples.
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arterial and venous bloods were sampled simultaneously.
Among other subtle differences, the significantly higher (p =
0.0002) abundance of the metabolite feature with m/z
309.280, putatively identified as eicosenoic acid, has been
observed in arterial blood, as shown by the paired plot (Figure
2b).
A typical untargeted metabolomic experiment comparing
any two conditions (e.g., normal vs disease) yields hundreds of
altered features. To visualize the results and filter out
significantly altered features, the original cloud plot18 has
been expanded from simply providing feature assignments (m/
z, retention time, p-value, and directional fold change) to the
interactive cloud plot or a dynamic interface enabling users to
customize the display (Figure 3 and 4). The default view
shows a “main panel” that allows users to modify p-value and
fold-change filters (Figure 3), where the thresholds can be
changed either by using a slider or the text box below the
slider. An “advanced” selection panel allows users to modify
m/z range, retention time, and ion-intensity range, depending
on the features of interest. Additional choices provided in the
advanced selection panel include multiple color options for up-
regulated and down-regulated metabolic features, options to
enable or disable TICs, colorize TICs, mark features with
METLIN hits19 and also to either show or hide isotopic peaks.
Furthermore, the “zoom” functionality allows users to focus
and magnify a desired area of the plot by dragging the cursor
across that area. This functionality is useful in plots with large
numbers of data points that cluster together. The plot can be
reset to the original view with a “mouse click”.
Cloud plots also facilitate characterization and structural
identification of metabolite features in untargeted metabolomic
experiments. For this purpose, the cloud plot is directly linked
Table 1. Statistical Tests and Interactive Visualization Tools Implemented within the XCMS Online Platform for Univariate
Analysis (One Variable at a Time)
univariate statistical analysis
experimental design
parametric test
(data follow normal distribution)
nonparametric alternative test
(no assumption about data distribution) visualization tools
comparison of two
independent groups
independent t test
(Welch t test)
Mann−Whitney interactive two-group cloud plot,
box−whisker plots,
extracted-ion chromatogramscomparison of two dependent
(paired or matched) groups
paired t test Wilcoxon signed-rank
comparison of ≥ three
independent groups
one-way ANOVA
with post-HOC
Kruskal−Wallis interactive multigroup cloud plot,
box−whisker plots,
extracted-ion chromatogramscomparison of ≥ three dependent
(matched or related) groups
repeated measures ANOVA Friedman
Figure 3. Dynamically generated images of the interactive cloud plot based on user-specified thresholds for p-value and fold change. The plot was
generated for an untargeted experiment comparing lymphoblastic leukemia cell lines (Raji parental vs SUP-T1 parental line). Each bubble in the
plot corresponds to a metabolite feature. Metabolite features are projected depending on their retention time (x-axis) and m/z (y-axis). The color
of the bubble denotes directionality of fold change and the size of the bubble denotes the extent of the fold change. Statistical significance (p-value)
is represented by the bubble’s color intensity. The features up-regulated in the SUP-T1 line compared to the Raji cell line are displayed in blue.
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to METLIN,20 the in-house developed standard database to
allow users to interrogate metabolite matches based on
accurate m/z measurements (Figure 4). Dysregulated features
with METLIN matches are designated with a dark outline
around the bubble, linking the user directly to the METLIN
metabolite page with a “mouse click”. METLIN contains 240
000+ metabolic entities of which 11 000+ have experimental
MS/MS spectra.
Meta-Analysis: Shared Metabolic Pattern Across
Multiple Experiments. Metabolomic studies can reveal
hundreds of dysregulated metabolic features, even using
stringent statistical criteria. Higher-order meta-analysis across
multiple experiments investigating a similar biological question
can allow for substantial data reduction.21,22 Meta-analysis can
be especially useful for untargeted metabolomic studies, where
the identification of metabolite features represents a bottle-
neck. The integration of data from multiple biologically
relevant studies facilitates the prioritization of interesting
metabolite features and increases the value and reliability of
results.21,23
Meta-analysis has already been extensively used in genome-
wide association studies to identify the susceptibility loci for
complex disorders24−26 and cancer gene expression signatures
when comparing multiple studies carried out by different
groups or using different technology platforms.27−29 It has also
been applied across different cancer types to identify general
signatures associated with cancer metabolism.30
An interface for meta-analysis has been implemented within
the XCMS Online platform to enable the identification of
shared homologous patterns of metabolic variation across the
results of multiple different experiments (Table 2). The main
interface is organized as a step-navigation wizard that allows
users to select the preprocessed experiments for comparison
and define threshold parameters for feature filtering and
chromatogram realignment. Metabolite features can be filtered
based on fold change, p-value, and ion intensity. Subsequently,
the metabolic profiles from multiple experiments are realigned
and the results of meta-analysis can be visualized by using two
different modalities, the traditional Venn diagram (Figure 5)
and the Edwards’s Venn diagram constructed as segments of a
sphere. Venn diagrams display the number of shared metabolic
features that are hyperlinked to a tabular output providing a
list of corresponding m/z and retention-time values along with
potential matches to the METLIN database.
As an example, the common pattern of stress response
among five different mutant strains of the sulfate-reducing
bacterium, Desulfovibrio alaskensis G20 was identified by meta-
analysis (Figure 5). The five different hypersensitive mutants
were derived from a fitness profiling experiment to identify the
mutants that were susceptible for salt stress as compared to the
wild type counterpart. Simple pairwise comparisons of each
mutant to their respective wild-type resulted in more than
1000 dysregulated metabolite features of statistical significance.
As shown in the Venn diagram, by using meta-analysis we were
able to reduce this number to three metabolites, which were
significantly altered in all of the different mutant strains versus
wild type bacteria culture, when subjected to short-term salt
stress. The putatively identified metabolites corresponded to
UDP-glucose, UMP, and UDP glucuronic acid, implying that
the cell-wall biosynthesis pathways31 may be perturbed as a
response to salt stress in all five hypersensitive mutant strains.
In a similar manner, meta-analysis has been used to compare
Figure 4. Interactive cloud plot with customized metabolomic data visualization. When a user scrolls the mouse over a bubble, feature assignments
are displayed in a pop-up window (m/z, RT, p-value, fold change) with potential METLIN hits. Each bubble is linked to the METLIN database to
provide putative identifications based on accurate m/z. When a bubble is selected by a mouse click, its EIC, box−whisker plot, and MS spectrum
appear on the bottom of the main panel. The feature with m/z 694.458 and a putative METLIN hit for glycerophosphoserine (PS) seems to be
specific to the SUP-T1 parental cell line.
Table 2. Interactive Visualization Tools Implemented within
XCMS Online Platform for Meta-Analysis
meta-analysis
experimental design method visualization tools
cross comparison of multiple
experiments
higher-order
analysis
Venn diagram, Edwards
diagram
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different models of pain where histamine has been identified as
a commonly altered metabolite.32
Multiple Group Comparisons: Metabolite Variation
Patterns Across Multiple Data Groups. Multiple group
analysis is an extension of two-group analysis that allows the
comparison of means for multiple independent groups (≥3)
and enables the identification of metabolite features whose
variation pattern is statistically significant. To evaluate the
metabolite variation across different experimental groups,
XCMS Online provides the univariate analysis of variance
(one-way ANOVA) as a parametric test option and the
Kruskal−Wallis test as its nonparametric alternative. The
Posthoc multiple comparison test is used to determine which
groups significantly differ in their metabolite expression
pattern.
To visualize the statistically significant results of multigroup
analysis and filter out the features of interest, the original two-
group cloud plot18 has been adapted for a multigroup output.
Multigroup cloud plots display the metabolite features whose
level varies significantly across different analyzed groups or
data classes. Metabolite features are projected in the same
manner as on two-group cloud plots, depending on their m/z
ratio and retention time. The new dynamic interface enables
users to adjust or determine the statistical significance
threshold (ANOVA or Kruskal−Wallis p-value), feature
intensity, m/z, and retention-time range for the best
representation of targeted features of interest. The box−
whisker plot, EIC, post-HOC values, and METLIN hits can be
visualized for each metabolic feature with a simple “mouse
click” on the specific bubble. The same example of wild type
and different mutants of Desulfovibrio alaskensis G20 exposed
to salt stress that was processed by the meta-analysis tools was
used to demonstrate the multigroup comparison. Relative to
meta-analysis where the objective was to identify the shared
pattern of metabolic response to stress, the multigroup analysis
highlighted the differences in the pattern of stress response
across wild type and different, hypersensitive mutants. Among
many differentially expressed features, the variation pattern of
glutamic acid across defined wild-type and mutant groups is
shown in Figure 6. During the exposure to salt stress, the
uptake and/or synthesis of glutamic acid was significantly up-
regulated in the lysine-aminomutase enzyme mutant (MUT-
34A9) when compared to the other mutants and wild type.
Multigroup analysis can be essential to discriminate the
metabolic response associated with a specific phenotype and
therefore to link specific metabolites with distinct functional
roles. For example, multigroup comparison could be used to
functionally characterize different brain regions or to identify
metabolic patterns specific to different types of cancer.
In the course of an untargeted metabolomic experiment,
many variables or metabolite features are measured simulta-
neously and the resulting data is multivariate data. Moreover,
the metabolites in a biochemical pathway behave in an
orchestrated way and tend to covary.33 This relation or
interaction between metabolites may be important in the
prediction of different groups or classes, and the differences
sometimes cannot be revealed by simply analyzing the
metabolites separately by univariate tests.33,34 Therefore, in
addition to the presented univariate statistical solutions, an
interactive multivariate principal component analysis (PCA)
has been implemented within the XCMS Online platform for
multigroup analysis. PCA is one of the most widely used
multivariate analysis tools in metabolomics, especially in the
case of untargeted metabolic profiling or fingerprinting. PCA
projects the original multidimensional data on a lower
dimensional space by capturing as much of the observed
variation as possible. It is based on the inherent data structure
Figure 5. Meta-analysis of the salt-stress response across five different mutant strains of Desulfovibrio alaskensis G20. The results of five two-group
comparisons (left). Shared patterns of stress response are characterized by significant up-regulation (p < 0.01) of three metabolites displayed in the
center of the Venn diagram (middle). The putative identity of those metabolites, verified by MS/MS matching to standards in METLIN, is shown
on the right. Mutant annotations: 143C7, transcriptional regulator (Cro/Cl family); 206E3, potassium uptake protein TrkA; 34A9, lysine 2,3-
aminomutase; 126cll, beta-lysine N-acetyltransferase; 116G4, V-type ATPase (subunit J, trk1).
Analytical Chemistry Article
dx.doi.org/10.1021/ac500734c | Anal. Chem. 2014, 86, 6931−69396936
and makes use of covariances or correlations among the
variables or metabolite features.
XCMS Online provides an interactive PCA report sheet,
including a scree plot, scores plot, and a loadings plot. The
scree plot is used to determine the appropriate number of
principal components needed to represent the maximum of
observed variation. The scores plot describes the relationship
between the samples and the loadings plot is useful for the
interpretation of the correlation between metabolites and how
they relate to the samples (Table 3). When the data from the
multigroup analysis of wild type and mutants of Desulfovibrio
alaskensis G20 were projected in two-dimensional space by
retaining the metabolite features that explain maximum
variation among different groups, three main clusters were
observed (Figure 7). Two mutants (for transcriptional
regulator, MUT-143C7; for ATP-ase subunit J, MUT-
116G4) hypersensitive to salt stress cluster separately, which
implies that they have specific metabolic responses to salt
stress in comparison to wild type and other mutants (PCA 1),
as well as to each other (PCA 2). Metabolite features that
drive this sample clustering can be identified on the loadings
plot. The metabolite features that show the largest possible
variance lie on the first principal component and those that
show subsequent largest variance lie on the second principal
component. Although the validity of the present PCA model
should be explored further, our purpose here was to
demonstrate the concept of the interactive PCA as a diagnostic
and interpretation tool for untargeted metabolomic experi-
ments. At its current stage of development, the display of
scree, scores, and loadings plots can be modified by a user
definition of standardization or scaling criteria (none/unit
variance/log/pareto), depending on the type of data. Scaling
gives the possibility of down-weighting irrelevant or noisy
features.
■ CONCLUSION
The untargeted metabolomic workflow relies on statistical data
analysis, result visualization, and data presentation, yet these
tasks often represent a considerable challenge for scientists
Figure 6. Interactive multigroup cloud plot with customized metabolomic data visualization. Metabolite features whose level varies significantly (p
< 0.01) across wild-type and different mutants are projected on the cloud plot depending on their retention time (x-axis) and m/z (y-axis). Each
metabolite feature is represented by a bubble. Statistical significance (p-value) is represented by the bubble’s color intensity. The size of the bubble
denotes feature intensity. When the user scrolls the mouse over a bubble, feature assignments are displayed in a pop-up window (m/z, RT, p-value,
fold change). When a bubble is selected by a “mouse click”, the EIC, Box-Whisker plot, Posthoc, and METLIN hits appear on the main panel. Each
bubble is linked to the METLIN database to provide putative identifications based on accurate m/z. The variation pattern of glutamic acid (m/z
146.0468, MS/MS METLIN match) across different mutants is shown by a box−whisker plot.
Table 3. Statistical Methods and Interactive Visualization
Tools Implemented within the XCMS Online Platform for
Multivariate Analysis (Multiple Variables Simultaneously)
multivariate statistical analysis
experimental
design method visualization tools
two-group or
multigroup
comparison
principal component
analysis (PCA)
interactive scree, scores and
loadings plot
hierarchical cluster
analysis (HCA)
heat map, dendogram
Analytical Chemistry Article
dx.doi.org/10.1021/ac500734c | Anal. Chem. 2014, 86, 6931−69396937
with limited bioinformatic expertise. The significant growth of
the metabolomic community in the past few years has
accelerated the development of user-friendly informatic tools
for high-throughput analysis of large metabolomic data sets. In
the given context, the interactive XCMS Online platform was
developed as an easy-to-use web tool for complete data
processing, from raw data upload, peak detection, retention-
time correction, profile alignment, comprehensive statistical
data evaluation, and visualization to putative metabolite
identification. Key to performing more complex data analyses,
XCMS Online now incorporates paired two-group analysis,
meta-analysis, and multiple group analysis to fit different
experimental designs. An interactive visualization scheme has
been implemented within these new analysis methods. The
interactive, two-group and multigroup cloud plots allow users
to navigate across and filter out metabolic features of interest.
The variation pattern of each feature can be observed with a
box−whisker plot and extracted ion chromatograms. The
interactive PCA allows for visualization of the correlations
among samples and metabolite features that drive the sample
clustering. Finally, a direct link between XCMS Online and the
standard METLIN database provides users with putative
metabolite identification.
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